课题基金 / 基金详情

BCG immunisation to prevent allergy in children: an intervention trial

BCG immunisation to prevent allergy in children: an intervention trial
卡介苗免疫预防儿童过敏:一项干预试验
批准号:
nhmrc : 1051228
负责人:
A/Pr Katie Flanagan
金额:
$79.17万
依托单位国家:
澳大利亚
项目类别:
Project Grants
财政年份:
2013
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2013-01-01 至 2016-12-31

项目摘要

项目成果

A/Pr Katie Flanagan的其他基金

相似基金

相关文献

中文摘要
翻译
过敏性疾病(哮喘,湿疹,食物过敏)在全球范围内急剧上升,特别是在澳大利亚,高达30%的儿童受到影响。有证据表明,从小的研究表明,卡介苗免疫接种有有益的影响,防止过敏型免疫反应在以后的生活。在一项大型随机试验中,我们将通过监测婴儿期湿疹和食物敏感性来确定出生时BCG是否能预防过敏性疾病,这两种因素都能预测过敏倾向。
英文摘要
There has been a dramatic rise in allergic diseases (asthma, eczema, food allergy) worldwide and particularly in Australia, with up to 30% of children affected. There is evidence from small studies that BCG immunisation has beneficial effects that prevent an allergic type immune response later in life. In a large randomised trial we will determine whether BCG at birth prevents allergic disease by monitoring eczema and food sensitivity in infancy, both of which predict an allergic predisposition.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
VITAL: Vaccine immunomodulation throughout the aging lifespan
  • 批准号:
    nhmrc : 1141840
  • 项目类别:
    Project Grants
  • 资助金额:
    $53.76万
  • 财政年份:
    2018
  • 负责人:
    A/Pr Katie Flanagan
  • 依托单位:
VITAL: Vaccine immunomodulation throughout the aging lifespan
  • 批准号:
    nhmrc : GNT1141840
  • 项目类别:
    Project Grants
  • 资助金额:
    $79.51万
  • 财政年份:
    2018
  • 负责人:
    A/Pr Katie Flanagan
  • 依托单位:
Extending the MIS BAIR randomised trial of BCG to prevent childhood allergy and infection
  • 批准号:
    nhmrc : GNT1099676
  • 项目类别:
    Project Grants
  • 资助金额:
    $93.95万
  • 财政年份:
    2016
  • 负责人:
    A/Pr Katie Flanagan
  • 依托单位:
Extending the MIS BAIR randomised trial of BCG to prevent childhood allergy and infection
  • 批准号:
    nhmrc : 1099676
  • 项目类别:
    Project Grants
  • 资助金额:
    $64.96万
  • 财政年份:
    2016
  • 负责人:
    A/Pr Katie Flanagan
  • 依托单位:
海外基金